Gergely Pál

1.

Sipka, S., Bíró, T., Czifra, G., Griger, Z., Gergely, P., Brúgós, B., Tarr, T.: The role of protein kinase C isoenzymes in the pathogenesis of human autoimmune diseases.
Clin. Immunol. 241, 109071, 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Immunology

Q1 Immunology and Allergy

2.

Goyard, D., Kónya, B., Czifrák, K., Larini, P., Demontrond, F., Leroy, J., Balzarin, S., Tournier, M., Tousch, D., Petit, P., Duret, C., Maurel, P., Docsa, T., Gergely, P., Somsák, L., Praly, J. P., Azay-Milhau, J., Vidal, S.: Glucose-based spiro-oxathiazoles as in vivo anti-hyperglycemic agents through glycogen phosphorylase inhibition.
Org. Biomol. Chem. 18 (5), 931-940, 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

3.

Nagy, L., Béke, F., Juhász, L., Kovács, T., Juhász-Tóth, É., Docsa, T., Tóth, A., Gergely, P., Somsák, L., Bai, P.: Glycogen phosphorylase inhibitor, 2,3-bis[(2E)-3-(4-hydroxyphenyl)prop-2-enamido] butanedioic acid (BF142), improves baseline insulin secretion of MIN6 insulinoma cells.
PLoS One. 15 (9), 1-15, 2020.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

4.

Kun, S., Begum, J., Kyriakis, E., Stamati, E. C. V., Barkas, T. A., Szennyes, E., Bokor, É., Szabó, E. K., Stravodimos, G. A., Sipos, Á., Docsa, T., Gergely, P., Moffatt, C., Patraskaki, M. S., Kokolaki, M. C., Gkerdi, A., Skamnaki, V. T., Leonidas, D. D., Somsák, L., Hayes, J. M.: A multidisciplinary study of 3-(β-D-glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: computation, synthesis, crystallography and kinetics reveal new potent inhibitors.
Eur. J. Med. Chem. 147, 266-278, 2018.

doi DEA WoS Scopus

Journal metrics:

Q1 Drug Discovery

Q1 Medicine (miscellaneous)

Q1 Organic Chemistry

Q1 Pharmacology

5.

Nagy, L., Márton, J., Vida, A., Kis, G., Bokor, É., Kun, S., Gönczi, M., Docsa, T., Tóth, A., Antal, M., Gergely, P., Csóka, B., Pacher, P., Somsák, L., Bai, P.: Glycogen phosphorylase inhibition improves beta cell function.
Br. J. Pharmacol. 175 (2), 301-319, 2018.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmacology

6.

Katona, É., Juhász, T., Hajdú, T., Nagy, G., Kókai, E., Trencsényi, G., Gergely, P., Zákány, R.: PP2A szerepe a SOX9/CREB trnszkriciós faktorok és a RHAMM/CD44 interakciók szabályzásában humán melanoma sejtvonalakban.
In: Membrán-Transzport Konferencia : Poszter absztraktok, Remedicon Kft., Sümeg, 32, 2018.

DEA

7.

Gergely, P., Hodossy-Takács, E., Magyar, É.: Beszámoló az MTA Debreceni Területi Bizottsága (a DAB) 2016. évi munkájáról.
Debr. szle. 25 (2), 244-259, 2017.

DEA

8.

Bokor, É., Kyriakis, E., Solovou, T. G. A., Koppány, C., Kantsadi, A. L., Szabó, E. K., Szakács, A., Stravodimos, G. A., Docsa, T., Skamnaki, V. T., Zographos, S. E., Gergely, P., Leonidas, D. D., Somsák, L.: Nanomolar Inhibitors of Glycogen Phosphorylase Based on β-d-Glucosaminyl Heterocycles: A Combined Synthetic, Enzyme Kinetic, and Protein Crystallography Study.
J. Med. Chem. 60 (22), 9251-9262, 2017.

doi DEA WoS Scopus

Journal metrics:

D1 Drug Discovery

Q1 Molecular Medicine

9.

Bokor, É., Széles, Z., Docsa, T., Gergely, P., Somsák, L.: C-Glucopyranosyl-1,2,4-triazol-5-ones: synthesis and inhibition of glycogen phosphorylase.
Carbohydr. Res. 429, 128-134, 2016.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q3 Biochemistry

Q2 Medicine (miscellaneous)

Q2 Organic Chemistry

10.

Goyard, D., Kónya, B., Chajistamatiou, A. S., Chrysina, E. D., Leroy, J., Balzarin, S., Tournier, M., Tousch, D., Petit, P., Duret, C., Maurel, P., Somsák, L., Docsa, T., Gergely, P., Praly, J. P., Azay-Milhau, J., Vidal, S.: Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition.
Eur. J. Med. Chem. 108, 444-454, 2016.

doi DEA WoS Scopus

Journal metrics:

Q1 Drug Discovery

Q1 Medicine (miscellaneous)

Q1 Organic Chemistry

Q1 Pharmacology

11.

Szennyes, E., Bokor, É., Batta, G., Docsa, T., Gergely, P., Somsák, L.: Improved preparation of 4(5)-aryl-2-(β-D-glucopyranosyl)-imidazoles, the most efficient glucose analogue inhibitors of glycogen phosphorylase.
RSC Adv. 6 (97), 94787-94794, 2016.

doi DEA

Journal metrics:

Q1 Chemical Engineering (miscellaneous)

Q1 Chemistry (miscellaneous)

12.

Katona, É., Juhász, T., Somogyi, C., Hajdú, T., Szász, C., Rácz, K., Kókai, E., Gergely, P., Zákány, R.: PP2B and ERK1/2 regulate hyaluronan synthesis of HT168 and WM35 human melanoma cell lines.
Int. J. Oncol. 48 (3), 983-997, 2016.

doi DEA

Journal metrics:

Q2 Cancer Research

Q2 Oncology

13.

Kantsadi, A. L., Bokor, É., Kun, S., Stravodimos, G. A., Chatzileontiadou, D. S. M., Leonidas, D. D., Juhász-Tóth, É., Szakács, A., Batta, G., Docsa, T., Gergely, P., Somsák, L.: Synthetic, enzyme kinetic, and protein crystallographic studies of C-[béta]-D-glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver glycogen phosphorylase.
Eur. J. Med. Chem. 123, 737-745, 2016.

doi DEA

Journal metrics:

Q1 Drug Discovery

Q1 Medicine (miscellaneous)

Q1 Organic Chemistry

Q1 Pharmacology

14.

Donnier-Maréchal, M., Goyard, D., Folliard, V., Docsa, T., Gergely, P., Praly, J. P., Vidal, S.: 3-Glucosylated 5-amino-1,2,4-oxadiazoles: synthesis and evaluation as glycogen phosphorylase inhibitors.
Beilstein J. Org. Chem. 11, 499-503, 2015.

doi DEA

Journal metrics:

Q1 Organic Chemistry

15.

Bokor, É., Kun, S., Docsa, T., Gergely, P., Somsák, L.: 4(5)-Aryl-2-C-glucopyranosyl-imidazoles as New Nanomolar Glucose Analogue Inhibitors of Glycogen Phosphorylase.
ACS Med. Chem. Lett. 6, 1215-1219, 2015.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q1 Drug Discovery

Q1 Organic Chemistry

16.

Bokor, É., Szennyes, E., Csupász, T., Tóth, N., Docsa, T., Gergely, P., Somsák, L.: C-(2-Deoxy-D-arabino-hex-1-enopyranosyl)-oxadiazoles: synthesis of possible isomers and their evaluation as glycogen phosphorylase inhibitors.
Carbohydr. Res. 412, 71-79, 2015.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q3 Biochemistry

Q2 Medicine (miscellaneous)

Q2 Organic Chemistry

17.

Begum, J., Varga, G., Docsa, T., Gergely, P., Hayes, J. M., Juhász, L., Somsák, L.: Computationally motivated synthesis and enzyme kinetic evaluation of N-([beta]-D-glucopyranosyl)-1,2,4-triazolecarboxamides as glycogen phosphorylase inhibitors.
Med. Chem. Commun. 6 (1), 80-89, 2015.

doi DEA

Journal metrics:

Q2 Biochemistry

Q1 Pharmaceutical Science

18.

Docsa, T., Marics, B., Németh, J., Hüse, C., Somsák, L., Gergely, P., Peitl, B.: Insulin sensitivity is modified by a glycogen phosphorylase inhibitor: glucopyranosylidene-spiro-thiohydantoin in streptozotocin-induced diabetic rats.
Curr. Top. Med. Chem. 15 (23), 2390-2394, 2015.

DEA

Journal metrics:

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

19.

Kiss, B. K., Szántó, M., Szklenár, M., Brunyánszki, A., Marosvölgyi, T., Sárosi, E., Remenyik, É., Gergely, P., Virág, L., Decsi, T., Rühl, R., Bai, P.: Poly(ADP) ribose polymerase-1 ablation alters eicosanoid and docosanoid signaling and metabolism in a murine model of contact hypersensitivity.
Mol. Med. Rep. 11 (4), 2861-2867, 2015.

doi DEA

Journal metrics:

Q3 Biochemistry

Q3 Cancer Research

Q3 Genetics

Q3 Molecular Biology

Q3 Molecular Medicine

Q3 Oncology

20.

Somogyi, C., Matta, C., Földvári, Z., Juhász, T., Katona, É., Takács, R. Á., Hajdú, T., Dobrosi, N., Gergely, P., Zákány, R.: Polymodal Transient Receptor Potential Vanilloid (TRPV) Ion Channels in Chondrogenic Cells.
Int. J. Mol. Sci. 16 (8), 18412-18438, 2015.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

Q1 Spectroscopy

21.

Goyard, D., Docsa, T., Gergely, P., Praly, J. P., Vidal, S.: Synthesis of 4-amidomethyl-1-glucosyl-1,2,3-triazoles and evaluation as glycogen phosphorylase inhibitors.
Carbohydr. Res. 402, 245-251, 2015.

doi DEA

Journal metrics:

Q2 Analytical Chemistry

Q3 Biochemistry

Q2 Medicine (miscellaneous)

Q2 Organic Chemistry

22.

Szántó, M., Brunyánszki, A., Márton, J., Vámosi, G., Nagy, L., Fodor, T., Kiss, B. K., Virág, L., Gergely, P., Bai, P.: Deletion of PARP-2 induces hepatic cholesterol accumulation and decrease in HDL levels.
Biochim. Biophys. Acta. Mol. Basis Dis. 1842 (4), 594-602, 2014.

doi DEA

Journal metrics:

Q1 Molecular Biology

Q1 Molecular Medicine

23.

Czifrák, K., Páhi, A., Deák, S., Kiss-Szikszai, A., Kövér, K. E., Docsa, T., Gergely, P., Alexacou, K. M., Papakonstantinou, M., Leonidas, D. D., Zographos, S. E., Chrysina, E. D., Somsák, L.: Glucopyranosylidene-spiro-iminothiazolidinone, a New Bicyclic Ring System: Synthesis, Derivatization, and Evaluation for Inhibition of Glycogen Phosphorylase by Enzyme Kinetic and Crystallographic Methods.
Bioorg. Med. Chem. 22 (15), 4028-4041, 2014.

doi DEA

Journal metrics:

Q2 Biochemistry

Q2 Clinical Biochemistry

Q1 Drug Discovery

Q3 Molecular Biology

Q2 Molecular Medicine

Q1 Organic Chemistry

Q1 Pharmaceutical Science

24.

Juhász, T., Matta, C., Somogyi, C., Katona, É., Takács, R. Á., Soha, R. F., Szabó, I. A., Cserháti, C., Sződy, R., Karácsonyi, Z., Bakó, É., Gergely, P., Zákány, R.: Mechanical loading stimulates chondrogenesis via the PKA/CREB-Sox9 and PP2A pathways in chicken micromass cultures.
Cell. Signal. 26 (3), 468-482, 2014.

doi DEA

Journal metrics:

Q1 Cell Biology

25.

Kun, S., Bokor, É., Varga, G., Szőcs, B., Páhi, A., Czifrák, K., Tóth, M., Juhász, L., Docsa, T., Gergely, P., Somsák, L.: New synthesis of 3-(β-D-glucopyranosyl)-5-substituted-1,2,4- triazoles, nanomolar inhibitors of glycogen phosphorylase.
Eur. J. Med. Chem. 76, 567-579, 2014.

doi DEA

Journal metrics:

Q1 Drug Discovery

Q1 Medicine (miscellaneous)

Q1 Organic Chemistry

Q1 Pharmacology

Publication list